Skip to main content
Contact Us
Sign Up
Subscriber Sign In
English
日本語
navigation
Search
What We Do
Vantage
News
Analysis
Policy & Pricing
Data Insights
Events
Medtech
Therapy Areas
About Vantage
Editorial team
Products & Services
Consensus Forecasts
Pharma
EvaluatePharma
EvaluatePharma Vision
Custom Solutions
How We Can Help You
Pharma and Biotech
Medtech
Financial Services
Management Consultancies
Service Providers
Client Success
Customer Testimonials
Thought Leadership
English
日本語
About Us
Media Centre
Press Releases
Media Coverage
Executive Team
Vision & History
Careers
Current Vacancies
Contact Us
Sign Up for Vantage
Subscriber Sign In
Search
Open configuration options
Search
Vantage
News
Snippets
Deals
Trial results
Patents and litigation
Corporate strategy
Analysis
Interviews
Spotlight
Vantage points
Vantage views
Policy & Pricing
Policy & Regulation
Pricing
Data Insights
M&A
IPO
NME approvals
Quarterly shareprice performance
Venture financing
Vantage data points
Other data
Events
Company events
Conferences
Upcoming events
Medtech
Therapy Areas
About
Editorial team
August 06, 2019
Share price movers – July 2019
Edwin Elmhirst
Related Companies
Achillion Pharmaceuticals
Amneal Pharmaceuticals
Lexicon Pharmaceuticals
Marinus Pharmaceuticals
Mezzion Pharma
Oasmia Pharmaceutical
Polyphor
scPharmaceuticals
Silence Therapeutics
Download PDF
Share This Article
We use cookies on this website. By using this site, you agree that we may store and access cookies on your device.
Find out more.
OK
Kickstarting ideas
Independent, data-driven daily news and analysis on pharma, biotech and medtech.
Sign up
Latest Reports
July 31, 2019
Vantage Pharma, Biotech & Medtech Half-Year Review 2019
February 26, 2019
Vantage Pharma, Biotech and Medtech 2018 in Review
Related Articles
April 04, 2011
Pharmasset the stand out small cap performer in first quarter
April 04, 2011
Pharmasset the stand out small cap performer in first quarter
August 15, 2019
Biopharma's biggest sellers – looking forward
March 20, 2019
Sage’s depression therapy arrives with big spread in sales forecasts
July 02, 2018
June rush drives near-record quarter for biotech flotations
Editor's Picks
September 05, 2019
Esmo 2019 preview – Parps on parade
September 10, 2019
Alzheimer's setbacks have prompted $39bn of market cap losses this year
September 12, 2019
Should the diabetes development road end for Sanofi?
August 27, 2019
Six burning Otezla questions
August 29, 2019
The PCSK9 wars continue, but at what cost?
